EKF Diagnostics
EKF Diagnostics is a leading global diagnostics and biotechnology company specializing in the development, production and distribution of leading medical technologies and patient-centric solutions. Their diagnostic technologies and biotechnology solutions empower healthcare professionals and non-medical practitioners to make informed decisions through point-of-care testing and life sciences applications.
Latest EKF Diagnostics Content
Product News
EKF Introduces Hand-Held Hemoglobin Analyzer With Secure POC Connectivity
EKF Diagnostics announces an enhanced DiaSpect Tm, that now connects securely to the company’s own point-of-care middleware, enabling additional features including a calculated hematocrit value and data management.
Video
Lucica® Glycated Albumin-L Test for diabetes: Comparisons and Clinical Utility With Shane O’Neill
In this episode we are joined by Shane O’Neill, director of scientific affairs at EKF Diagnostics. Shane provides an introduction to the glycated albumin (GA) test for intermediate-term glycemic control in diabetic patients.
Product News
EKF To Highlight Specific Glycemic Control Marker at AACC 2022
EKF Diagnostics will be at the 2022 AACC Clinical Lab Expo, Chicago IL, July 26-28, exhibiting its range of laboratory and point-of-care diagnostics products on Booth #3637.
Product News
EKF Launches Middleware Connectivity Solution for POC Analyzers and Data Management
EKF Diagnostics, the global in vitro diagnostics company, announces the launch of its new EKF Link digital connectivity solution for the secure management of point-of-care (POC) analyzers and associated data on one centralized platform.
Advertisement
